NeuroMetrix

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

You can watch NeuroMetrix and buy or sell other stocks, ETFs, and their options commission-free!

About NURO

NeuroMetrix, Inc. engages in the development and manufacture of diagnostic and therapeutic neurostimulation-based medical devices. Its products include DPNCheck, Quell, and ADVANCE system. 

CEO
Daniel S. Goldberger
CEODaniel S. Goldberger
Employees
13
Employees13
Headquarters
Woburn, Massachusetts
HeadquartersWoburn, Massachusetts
Founded
1996
Founded1996
Employees
13
Employees13

NURO Key Statistics

Market cap
9.39M
Market cap9.39M
Price-Earnings ratio
-1.14
Price-Earnings ratio-1.14
Dividend yield
Dividend yield
Average volume
Average volume
High today
High today
Low today
Low today
Open price
Open price
Volume
0.00
Volume0.00
52 Week high
$4.73
52 Week high$4.73
52 Week low
$3.22
52 Week low$3.22

Stock Snapshot

As of today, NeuroMetrix(NURO) shares are valued at $4.58. The company's market cap stands at 9.39M, with a P/E ratio of -1.14.

NeuroMetrix(NURO) stock opened on 2026-02-19 at —. The price climbed to — and dipped to —.

The NeuroMetrix(NURO)'s current trading volume is 0.

In the last year, NeuroMetrix(NURO) shares hit a 52-week high of $4.73 and a 52-week low of $3.22.

In the last year, NeuroMetrix(NURO) shares hit a 52-week high of $4.73 and a 52-week low of $3.22.

People also own

Based on the portfolios of people who own NURO. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.